China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$2.83−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $2.71MP/E –Yield –
China SXT Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$2.35M. The highest annual figure on record is $1.48M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$2.35M | – |
| FY2024 | Mar 31, 2024 | -$1.94M | -340.9% |
| FY2020 | Mar 31, 2020 | $803.41K | – |
| FY2019 | Mar 31, 2019 | -$296.63K | -120.0% |
| FY2018 | Mar 31, 2018 | $1.48M | +1203.4% |
| FY2017 | Mar 31, 2017 | $113.87K | – |
See a number that looks wrong?